Donald J. Santel - 19 Jan 2023 Form 3 Insider Report for Aerovate Therapeutics, Inc. (JBIO)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Issuer symbol
JBIO
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
23 Jan 2023, 16:59:27 UTC
Previous filing
04 Jan 2023
Next filing
08 Jun 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney